JPRN-UMIN000014467已完成未知
Research of second line anti-diabetes drug for patients with Type-2 diabetes who received Sitagliptin as first line. - Research of second line anti-diabetes drug for patients with Type-2 diabetes who received Sitagliptin as first line.
Fukuoka Tokushukai Medical Center Psychosomatic Medicine0 个研究点目标入组 132 人开始时间: 2014年7月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 132
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Moderate to severe renal dysfunction Dialysis patient Medical history of heart failure,bowel obstruction
研究者
相似试验
尚未招募
Unknown
A study to assess the effect of a combination of glucose lowering medicines in prevention of type 2 diabetes among women with previous history of gestational diabetes mellitus and having pre-diabetesCTRI/2024/05/067588Indian Council of Medical Research (ICMR)
招募中
3 期
Anti-diabetic Herbal DrugDiabetes type2.oral antidiabetic drugsZ79.84IRCT20170809035599N2Ahvaz University of Medical Sciences140
尚未招募
3 期
Evaluating safety and efficacy of zinc ang magnesium supplements in Type 2 diabetic patients along with standard care of treatamentCTRI/2024/07/071237Dr Santra Sunny (self)
已完成
1 期
A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes PatientsType 2 Diabetes PatientsNCT01298518Pfizer48
已完成
不适用
Study on insulin treatment for type 2 diabetes performed by general practitionersType 2 diabetes mellitusJPRN-UMIN000011287General incorporated Tokyo Physicians Association.100